✉: [email protected]📞: +91 921-809-3694
c87e310c pharmacology 1 scaled

Research and Reviews: A Journal of Pharmacology

2230-9861 2349-1299 Peer‑Reviewed | Subscription‑Based

rrjop Volume: 14, Issue: 03 Year: 2024

13

Regular Issue  Subscription Review Article Published on :- Dec 31, 2024
By  

 

Tanusha Pillai, Sunitha M, Ganesh N.S,
Abstract : Dasatinib (Das) is a second-generation tyrosine kinase inhibitor that is used in the treatment of chronic myelogenous leukemia (CML) in patients who read more

[This section belongs to Research & Reviews: A Journal of Pharmacology (rrjop)]

 

 

92-95
Regular Issue  Subscription Review Article Published on :- Dec 31, 2024
By  

 

Navaneeth Krishna B,
Abstract : Semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1RA), has emerged as a versatile therapeutic agent with significant potential in managing read more

[This section belongs to Research & Reviews: A Journal of Pharmacology (rrjop)]

 

 

96-104
Regular Issue  Subscription Review Article Published on :- Dec 31, 2024
By  

 

R. Ganesh.,
Abstract : According to Medicine, India’s over-the-counter drug market is growing .The country’s economy is expanding.The Indian pharmaceutical industry has read more

[This section belongs to Research & Reviews: A Journal of Pharmacology (rrjop)]

 

 

105-112

Editorial Board

View Full Editorial Board

rrjop maintains an Editorial Board of practicing researchers from around the world, to ensure manuscripts are handled by editors who are experts in the field of study.

Editor in Chief

Editor

Dr. Laxmikant Borse, Principal

Sandip Institute of Pharmaceutical Sciences, Nashik, Maharashtra, India, 422213

Email :